The metabolic enzyme indoleamine 2,3-dioxygenase (IDO1) has been suggested as a biological mediator of inflammation in the psychopathology of depression, with increased KYN in the tryptophan (TRP) metabolic pathway resulting in reduced serotonin [44]. Here, IDO2 is linked to depressive disorder.